VANCOUVER, BC, Nov. 14, 2023 /CNW/ – TSX VENTURE COMPANIES ATHABASCA MINERALS INC. (“AMI”) BULLETIN TYPE: Suspend BULLETIN DATE: November…
Category: News Headlines
View the latest news and breaking news today
CANACCORD GENUITY GROUP INC. REPORTS SECOND QUARTER FISCAL 2024 RESULTS
Earnings contributions from global wealth management businesses helped to offset the impact of prolonged weak conditions…
Medtronic to announce financial results for its second quarter of fiscal year 2024
DUBLIN, Nov. 7, 2023 /CNW/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced…
AtkinsRéalis-led consortium receives award letter for engineering, technology and procurement in support of CANDU reactor life extension in Romania
MONTREAL, Nov. 7, 2023 /CNW/ – Candu Energy Inc., an AtkinsRéalis company [SNC-Lavalin Group Inc.] (TSX: ATRL) and the Canadian…
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. RICHARD LAJOIE TO BOARD OF DIRECTORS
MONTREAL, Nov. 7, 2023 /CNW/ – Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company“),…
SUNRATE and Sabre sign agreement to elevate the business payments experience in the Asia-Pacific region
SINGAPORE, Oct. 24, 2023 /CNW/ — SUNRATE, the intelligent global payment and treasury management platform, and Sabre, a leading…
RECONAFRICA ENGAGES INDEPENDENT TRADING GROUP AS MARKET MAKER
VANCOUVER, BC, Oct. 24, 2023 /CNW/ – Reconnaissance Energy Africa Ltd. (the “Company” or “ReconAfrica”) (TSXV: RECO) (OTCQX:…
Almost two-thirds of young Montrealers in favor of self-service e-scooter program returning to Montreal in 2024
MONTRÉAL, Oct. 16, 2023 /CNW/ – Bird Global, Inc. (NYSE:BRDS) (“Bird”), the largest and most popular sustainable micromobility…
NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST ANNOUNCES PROPOSED AMENDMENTS AND EXTENSION OF CONVERTIBLE DEBENTURES
TORONTO, Oct. 16, 2023 /CNW/ – Northwest Healthcare Properties Real Estate Investment Trust (the “REIT” or “Northwest“) (TSX:…
Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023
Preliminary updated PDAC data show 6-month overall survival rate of 82% Results from pelareorep combination in…